img

Global Phosphodiesterase (PDE) inhibitors Sales Market Report 2024


Published on: 2024-01-04 | No of Pages : 334 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Phosphodiesterase (PDE) inhibitors Sales Market Report 2024

The global Phosphodiesterase (PDE) inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Phosphodiesterase (PDE) inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
PDE1 Selective Inhibitors
PDE2 Selective Inhibitors
PDE3 Selective Inhibitors
PDE4 selective inhibitors
PDE5 selective inhibitors
PDE7 selective inhibitors
PDE10 selective inhibitors


Segment by Application


Oral
Topical
Other

The Phosphodiesterase (PDE) inhibitors market is analysed and market size information is provided by regions (countries).

Segment by Application

, the Phosphodiesterase (PDE) inhibitors market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.




By Company


Bayer AG
Eli Lilly and Co.
GlaxoSmithKline Plc
Pfizer Inc.
Vivus Inc.

Table of Content

1 Phosphodiesterase (PDE) inhibitors Market Overview
1.1 Phosphodiesterase (PDE) inhibitors Product Scope
1.2 Phosphodiesterase (PDE) inhibitors Segment by Type
1.2.1 Global Phosphodiesterase (PDE) inhibitors Sales by Type (2016 & 2021 & 2027)
1.2.2 PDE1 Selective Inhibitors
1.2.3 PDE2 Selective Inhibitors
1.2.4 PDE3 Selective Inhibitors
1.2.5 PDE4 selective inhibitors
1.2.6 PDE5 selective inhibitors
1.2.7 PDE7 selective inhibitors
1.2.8 PDE10 selective inhibitors
1.3 Phosphodiesterase (PDE) inhibitors Segment by Application
1.3.1 Global Phosphodiesterase (PDE) inhibitors Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oral
1.3.3 Topical
1.3.4 Other
1.4 Phosphodiesterase (PDE) inhibitors Market Estimates and Forecasts (2016-2027)
1.4.1 Global Phosphodiesterase (PDE) inhibitors Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Phosphodiesterase (PDE) inhibitors Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Phosphodiesterase (PDE) inhibitors Price Trends (2016-2027)

2 Phosphodiesterase (PDE) inhibitors Estimates and Forecasts by Region
2.1 Global Phosphodiesterase (PDE) inhibitors Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Phosphodiesterase (PDE) inhibitors Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Region (2016-2021)
2.2.2 Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Region (2016-2021)
2.3 Global Phosphodiesterase (PDE) inhibitors Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Phosphodiesterase (PDE) inhibitors Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Phosphodiesterase (PDE) inhibitors Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Phosphodiesterase (PDE) inhibitors Estimates and Projections (2016-2027)
2.4.2 Europe Phosphodiesterase (PDE) inhibitors Estimates and Projections (2016-2027)
2.4.3 China Phosphodiesterase (PDE) inhibitors Estimates and Projections (2016-2027)
2.4.4 Japan Phosphodiesterase (PDE) inhibitors Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Phosphodiesterase (PDE) inhibitors Estimates and Projections (2016-2027)
2.4.6 India Phosphodiesterase (PDE) inhibitors Estimates and Projections (2016-2027)
3 Global Phosphodiesterase (PDE) inhibitors Competition Landscape by Players
3.1 Global Top Phosphodiesterase (PDE) inhibitors Players by Sales (2016-2021)
3.2 Global Top Phosphodiesterase (PDE) inhibitors Players by Revenue (2016-2021)
3.3 Global Phosphodiesterase (PDE) inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Phosphodiesterase (PDE) inhibitors as of 2020)
3.4 Global Phosphodiesterase (PDE) inhibitors Average Price by Company (2016-2021)
3.5 Manufacturers Phosphodiesterase (PDE) inhibitors Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Phosphodiesterase (PDE) inhibitors Market Size by Type
4.1 Global Phosphodiesterase (PDE) inhibitors Historic Market Review by Type (2016-2021)
4.1.1 Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2016-2021)
4.1.2 Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Type (2016-2021)
4.1.3 Global Phosphodiesterase (PDE) inhibitors Price by Type (2016-2021)
4.2 Global Phosphodiesterase (PDE) inhibitors Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Phosphodiesterase (PDE) inhibitors Sales Forecast by Type (2022-2027)
4.2.2 Global Phosphodiesterase (PDE) inhibitors Revenue Forecast by Type (2022-2027)
4.2.3 Global Phosphodiesterase (PDE) inhibitors Price Forecast by Type (2022-2027)
5 Global Phosphodiesterase (PDE) inhibitors Market Size by Application
5.1 Global Phosphodiesterase (PDE) inhibitors Historic Market Review by Application (2016-2021)
5.1.1 Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2016-2021)
5.1.2 Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Application (2016-2021)
5.1.3 Global Phosphodiesterase (PDE) inhibitors Price by Application (2016-2021)
5.2 Global Phosphodiesterase (PDE) inhibitors Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Phosphodiesterase (PDE) inhibitors Sales Forecast by Application (2022-2027)
5.2.2 Global Phosphodiesterase (PDE) inhibitors Revenue Forecast by Application (2022-2027)
5.2.3 Global Phosphodiesterase (PDE) inhibitors Price Forecast by Application (2022-2027)

6 North America Phosphodiesterase (PDE) inhibitors Market Facts & Figures
6.1 North America Phosphodiesterase (PDE) inhibitors Sales by Company
6.1.1 North America Phosphodiesterase (PDE) inhibitors Sales by Company (2016-2021)
6.1.2 North America Phosphodiesterase (PDE) inhibitors Revenue by Company (2016-2021)
6.2 North America Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type
6.2.1 North America Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2016-2021)
6.2.2 North America Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2022-2027)
6.3 North America Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application
6.3.1 North America Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application (2016-2021)
6.3.2 North America Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application (2022-2027)

7 Europe Phosphodiesterase (PDE) inhibitors Market Facts & Figures
7.1 Europe Phosphodiesterase (PDE) inhibitors Sales by Company
7.1.1 Europe Phosphodiesterase (PDE) inhibitors Sales by Company (2016-2021)
7.1.2 Europe Phosphodiesterase (PDE) inhibitors Revenue by Company (2016-2021)
7.2 Europe Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type
7.2.1 Europe Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2016-2021)
7.2.2 Europe Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2022-2027)
7.3 Europe Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application
7.3.1 Europe 132 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 132 Sales Breakdown by Application (2022-2027)

8 China Phosphodiesterase (PDE) inhibitors Market Facts & Figures
8.1 China Phosphodiesterase (PDE) inhibitors Sales by Company
8.1.1 China Phosphodiesterase (PDE) inhibitors Sales by Company (2016-2021)
8.1.2 China Phosphodiesterase (PDE) inhibitors Revenue by Company (2016-2021)
8.2 China Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type
8.2.1 China Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2016-2021)
8.2.2 China Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2022-2027)
8.3 China Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)

9 Japan Phosphodiesterase (PDE) inhibitors Market Facts & Figures
9.1 Japan Phosphodiesterase (PDE) inhibitors Sales by Company
9.1.1 Japan Phosphodiesterase (PDE) inhibitors Sales by Company (2016-2021)
9.1.2 Japan Phosphodiesterase (PDE) inhibitors Revenue by Company (2016-2021)
9.2 Japan Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type
9.2.1 Japan Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2016-2021)
9.2.2 Japan Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2022-2027)
9.3 Japan Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Phosphodiesterase (PDE) inhibitors Market Facts & Figures
10.1 Southeast Asia Phosphodiesterase (PDE) inhibitors Sales by Company
10.1.1 Southeast Asia Phosphodiesterase (PDE) inhibitors Sales by Company (2016-2021)
10.1.2 Southeast Asia Phosphodiesterase (PDE) inhibitors Revenue by Company (2016-2021)
10.2 Southeast Asia Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type
10.2.1 Southeast Asia Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application
10.3.1 Southeast Asia K Liter Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Liter Sales Breakdown by Application (2022-2027)

11 India Phosphodiesterase (PDE) inhibitors Market Facts & Figures
11.1 India Phosphodiesterase (PDE) inhibitors Sales by Company
11.1.1 India Phosphodiesterase (PDE) inhibitors Sales by Company (2016-2021)
11.1.2 India Phosphodiesterase (PDE) inhibitors Revenue by Company (2016-2021)
11.2 India Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type
11.2.1 India Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2016-2021)
11.2.2 India Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2022-2027)
11.3 India Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application
11.3.1 India Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application (2016-2021)
11.3.2 India Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Phosphodiesterase (PDE) inhibitors Business
12.1 Bayer AG
12.1.1 Bayer AG Corporation Information
12.1.2 Bayer AG Business Overview
12.1.3 Bayer AG Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer AG Phosphodiesterase (PDE) inhibitors Products Offered
12.1.5 Bayer AG Recent Development
12.2 Eli Lilly and Co.
12.2.1 Eli Lilly and Co. Corporation Information
12.2.2 Eli Lilly and Co. Business Overview
12.2.3 Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Products Offered
12.2.5 Eli Lilly and Co. Recent Development
12.3 GlaxoSmithKline Plc
12.3.1 GlaxoSmithKline Plc Corporation Information
12.3.2 GlaxoSmithKline Plc Business Overview
12.3.3 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.3.4 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Products Offered
12.3.5 GlaxoSmithKline Plc Recent Development
12.4 Pfizer Inc.
12.4.1 Pfizer Inc. Corporation Information
12.4.2 Pfizer Inc. Business Overview
12.4.3 Pfizer Inc. Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Inc. Phosphodiesterase (PDE) inhibitors Products Offered
12.4.5 Pfizer Inc. Recent Development
12.5 Vivus Inc.
12.5.1 Vivus Inc. Corporation Information
12.5.2 Vivus Inc. Business Overview
12.5.3 Vivus Inc. Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Vivus Inc. Phosphodiesterase (PDE) inhibitors Products Offered
12.5.5 Vivus Inc. Recent Development
...

13 Phosphodiesterase (PDE) inhibitors Manufacturing Cost Analysis
13.1 Phosphodiesterase (PDE) inhibitors Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Phosphodiesterase (PDE) inhibitors
13.4 Phosphodiesterase (PDE) inhibitors Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Phosphodiesterase (PDE) inhibitors Distributors List
14.3 Phosphodiesterase (PDE) inhibitors Customers

15 Market Dynamics
15.1 Phosphodiesterase (PDE) inhibitors Market Trends
15.2 Phosphodiesterase (PDE) inhibitors Drivers
15.3 Phosphodiesterase (PDE) inhibitors Market Challenges
15.4 Phosphodiesterase (PDE) inhibitors Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Phosphodiesterase (PDE) inhibitors Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Phosphodiesterase (PDE) inhibitors Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Phosphodiesterase (PDE) inhibitors Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Phosphodiesterase (PDE) inhibitors Sales (K Liter) by Region (2016-2021)
Table 5. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Region (2016-2021)
Table 6. Global Phosphodiesterase (PDE) inhibitors Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Phosphodiesterase (PDE) inhibitors Revenue Share by Region (2016-2021)
Table 8. Global Phosphodiesterase (PDE) inhibitors Sales (K Liter) Forecast by Region (2022-2027)
Table 9. Global Phosphodiesterase (PDE) inhibitors Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Phosphodiesterase (PDE) inhibitors Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Phosphodiesterase (PDE) inhibitors Revenue Share Forecast by Region (2022-2027)
Table 12. Global Phosphodiesterase (PDE) inhibitors Sales (K Liter) of Key Companies (2016-2021)
Table 13. Global Phosphodiesterase (PDE) inhibitors Sales Share by Company (2016-2021)
Table 14. Global Phosphodiesterase (PDE) inhibitors Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Phosphodiesterase (PDE) inhibitors Revenue Share by Company (2016-2021)
Table 16. Global Phosphodiesterase (PDE) inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Phosphodiesterase (PDE) inhibitors as of 2020)
Table 17. Global Phosphodiesterase (PDE) inhibitors Average Price (USD/Liter) of Key Company (2016-2021)
Table 18. Manufacturers Phosphodiesterase (PDE) inhibitors Manufacturing Sites and Area Served
Table 19. Manufacturers Phosphodiesterase (PDE) inhibitors Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Phosphodiesterase (PDE) inhibitors Sales (K Liter) by Type (2016-2021)
Table 22. Global Phosphodiesterase (PDE) inhibitors Sales Share by Type (2016-2021)
Table 23. Global Phosphodiesterase (PDE) inhibitors Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Phosphodiesterase (PDE) inhibitors Price (USD/Liter) by Type (2016-2021)
Table 25. Global Phosphodiesterase (PDE) inhibitors Sales Share by Type (2022-2027)
Table 26. Global Phosphodiesterase (PDE) inhibitors Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Phosphodiesterase (PDE) inhibitors Revenue Share by Type (2022-2027)
Table 28. Global Phosphodiesterase (PDE) inhibitors Price (USD/Liter) by Type (2022-2027)
Table 29. Global Phosphodiesterase (PDE) inhibitors Sales (K Liter) by Application (2016-2021)
Table 30. Global Phosphodiesterase (PDE) inhibitors Sales Share by Application (2016-2021)
Table 31. Global Phosphodiesterase (PDE) inhibitors Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Phosphodiesterase (PDE) inhibitors Price (USD/Liter) by Application (2016-2021)
Table 33. Global Phosphodiesterase (PDE) inhibitors Sales (K Liter) by Application (2022-2027)
Table 34. Global Phosphodiesterase (PDE) inhibitors Sales Share by Application (2022-2027)
Table 35. Global Phosphodiesterase (PDE) inhibitors Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Phosphodiesterase (PDE) inhibitors Revenue Share by Application (2022-2027)
Table 37. Global Phosphodiesterase (PDE) inhibitors Price (USD/Liter) by Application (2022-2027)
Table 38. North America Phosphodiesterase (PDE) inhibitors Sales (K Liter) by Company (2016-2021)
Table 39. North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Company (2016-2021)
Table 40. North America Phosphodiesterase (PDE) inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Phosphodiesterase (PDE) inhibitors Revenue Market Share by Company (2016-2021)
Table 42. North America Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2021) & (K Liter)
Table 43. North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2016-2021)
Table 44. North America Phosphodiesterase (PDE) inhibitors Sales by Type (2022-2027) & (K Liter)
Table 45. North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2022-2027)
Table 46. North America Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2021) & (K Liter)
Table 47. North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2016-2021)
Table 48. North America Phosphodiesterase (PDE) inhibitors Sales by Application (2022-2027) & (K Liter)
Table 49. North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2022-2027)
Table 50. Europe Phosphodiesterase (PDE) inhibitors Sales (K Liter) by Company (2016-2021)
Table 51. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Company (2016-2021)
Table 52. Europe Phosphodiesterase (PDE) inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Phosphodiesterase (PDE) inhibitors Revenue Market Share by Company (2016-2021)
Table 54. Europe Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2021) & (K Liter)
Table 55. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2016-2021)
Table 56. Europe Phosphodiesterase (PDE) inhibitors Sales by Type (2022-2027) & (K Liter)
Table 57. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2022-2027)
Table 58. Europe Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2021) & (K Liter)
Table 59. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2016-2021)
Table 60. Europe Phosphodiesterase (PDE) inhibitors Sales by Application (2022-2027) & (K Liter)
Table 61. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2022-2027)
Table 62. China Phosphodiesterase (PDE) inhibitors Sales (K Liter) by Company (2016-2021)
Table 63. China Phosphodiesterase (PDE) inhibitors Sales Market Share by Company (2016-2021)
Table 64. China Phosphodiesterase (PDE) inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Phosphodiesterase (PDE) inhibitors Revenue Market Share by Company (2016-2021)
Table 66. China Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2021) & (K Liter)
Table 67. China Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2016-2021)
Table 68. China Phosphodiesterase (PDE) inhibitors Sales by Type (2022-2027) & (K Liter)
Table 69. China Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2022-2027)
Table 70. China Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2021) & (K Liter)
Table 71. China Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2016-2021)
Table 72. China Phosphodiesterase (PDE) inhibitors Sales by Application (2022-2027) & (K Liter)
Table 73. China Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2022-2027)
Table 74. Japan Phosphodiesterase (PDE) inhibitors Sales (K Liter) by Company (2016-2021)
Table 75. Japan Phosphodiesterase (PDE) inhibitors Sales Market Share by Company (2016-2021)
Table 76. Japan Phosphodiesterase (PDE) inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Phosphodiesterase (PDE) inhibitors Revenue Market Share by Company (2016-2021)
Table 78. Japan Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2021) & (K Liter)
Table 79. Japan Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2016-2021)
Table 80. Japan Phosphodiesterase (PDE) inhibitors Sales by Type (2022-2027) & (K Liter)
Table 81. Japan Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2022-2027)
Table 82. Japan Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2021) & (K Liter)
Table 83. Japan Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2016-2021)
Table 84. Japan Phosphodiesterase (PDE) inhibitors Sales by Application (2022-2027) & (K Liter)
Table 85. Japan Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Phosphodiesterase (PDE) inhibitors Sales (K Liter) by Company (2016-2021)
Table 87. Southeast Asia Phosphodiesterase (PDE) inhibitors Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Phosphodiesterase (PDE) inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Phosphodiesterase (PDE) inhibitors Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2021) & (K Liter)
Table 91. Southeast Asia Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Phosphodiesterase (PDE) inhibitors Sales by Type (2022-2027) & (K Liter)
Table 93. Southeast Asia Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2021) & (K Liter)
Table 95. Southeast Asia Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Phosphodiesterase (PDE) inhibitors Sales by Application (2022-2027) & (K Liter)
Table 97. Southeast Asia Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2022-2027)
Table 98. India Phosphodiesterase (PDE) inhibitors Sales (K Liter) by Company (2016-2021)
Table 99. India Phosphodiesterase (PDE) inhibitors Sales Market Share by Company (2016-2021)
Table 100. India Phosphodiesterase (PDE) inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Phosphodiesterase (PDE) inhibitors Revenue Market Share by Company (2016-2021)
Table 102. India Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2021) & (K Liter)
Table 103. India Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2016-2021)
Table 104. India Phosphodiesterase (PDE) inhibitors Sales by Type (2022-2027) & (K Liter)
Table 105. India Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2022-2027)
Table 106. India Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2021) & (K Liter)
Table 107. India Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2016-2021)
Table 108. India Phosphodiesterase (PDE) inhibitors Sales by Application (2022-2027) & (K Liter)
Table 109. India Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2022-2027)
Table 110. Bayer AG Corporation Information
Table 111. Bayer AG Description and Business Overview
Table 112. Bayer AG Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 113. Bayer AG Phosphodiesterase (PDE) inhibitors Product
Table 114. Bayer AG Recent Development
Table 115. Eli Lilly and Co. Corporation Information
Table 116. Eli Lilly and Co. Description and Business Overview
Table 117. Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 118. Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Product
Table 119. Eli Lilly and Co. Recent Development
Table 120. GlaxoSmithKline Plc Corporation Information
Table 121. GlaxoSmithKline Plc Description and Business Overview
Table 122. GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 123. GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Product
Table 124. GlaxoSmithKline Plc Recent Development
Table 125. Pfizer Inc. Corporation Information
Table 126. Pfizer Inc. Description and Business Overview
Table 127. Pfizer Inc. Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 128. Pfizer Inc. Phosphodiesterase (PDE) inhibitors Product
Table 129. Pfizer Inc. Recent Development
Table 130. Vivus Inc. Corporation Information
Table 131. Vivus Inc. Description and Business Overview
Table 132. Vivus Inc. Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2016-2021)
Table 133. Vivus Inc. Phosphodiesterase (PDE) inhibitors Product
Table 134. Vivus Inc. Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Phosphodiesterase (PDE) inhibitors Distributors List
Table 138. Phosphodiesterase (PDE) inhibitors Customers List
Table 139. Phosphodiesterase (PDE) inhibitors Market Trends
Table 140. Phosphodiesterase (PDE) inhibitors Market Drivers
Table 141. Phosphodiesterase (PDE) inhibitors Market Challenges
Table 142. Phosphodiesterase (PDE) inhibitors Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Phosphodiesterase (PDE) inhibitors Product Picture
Figure 2. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Application in 2021 & 2027
Figure 6. Oral Examples
Figure 7. Topical Examples
Figure 8. Other Examples
Figure 9. Global Phosphodiesterase (PDE) inhibitors Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Phosphodiesterase (PDE) inhibitors Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Phosphodiesterase (PDE) inhibitors Sales (K Liter) Growth Rate (2016-2027)
Figure 12. Global Phosphodiesterase (PDE) inhibitors Price Trends Growth Rate (2016-2027) (USD/Liter)
Figure 13. Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Phosphodiesterase (PDE) inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Phosphodiesterase (PDE) inhibitors Sales (K Liter) Growth Rate (2016-2027)
Figure 17. Europe Phosphodiesterase (PDE) inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Phosphodiesterase (PDE) inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Phosphodiesterase (PDE) inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Phosphodiesterase (PDE) inhibitors Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Phosphodiesterase (PDE) inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Phosphodiesterase (PDE) inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Phosphodiesterase (PDE) inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Phosphodiesterase (PDE) inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Phosphodiesterase (PDE) inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Phosphodiesterase (PDE) inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Phosphodiesterase (PDE) inhibitors Players Market Share by Revenue in Phosphodiesterase (PDE) inhibitors: 2016 & 2020
Figure 28. Phosphodiesterase (PDE) inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Phosphodiesterase (PDE) inhibitors Revenue Share by Type (2016-2021)
Figure 30. Global Phosphodiesterase (PDE) inhibitors Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Phosphodiesterase (PDE) inhibitors Revenue Share by Application (2016-2021)
Figure 32. Global Phosphodiesterase (PDE) inhibitors Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Type in 2020
Figure 34. North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Application in 2020
Figure 35. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Type in 2020
Figure 36. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Application in 2020
Figure 37. China Phosphodiesterase (PDE) inhibitors Sales Market Share by Type in 2020
Figure 38. China Phosphodiesterase (PDE) inhibitors Sales Market Share by Application in 2020
Figure 39. Japan Phosphodiesterase (PDE) inhibitors Sales Market Share by Type in 2020
Figure 40. Japan Phosphodiesterase (PDE) inhibitors Sales Market Share by Application in 2020
Figure 41. Southeast Asia Phosphodiesterase (PDE) inhibitors Sales Market Share by Type in 2020
Figure 42. Southeast Asia Phosphodiesterase (PDE) inhibitors Sales Market Share by Application in 2020
Figure 43. India Phosphodiesterase (PDE) inhibitors Sales Market Share by Type in 2020
Figure 44. India Phosphodiesterase (PDE) inhibitors Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Phosphodiesterase (PDE) inhibitors
Figure 47. Manufacturing Process Analysis of Phosphodiesterase (PDE) inhibitors
Figure 48. Phosphodiesterase (PDE) inhibitors Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed